Feature | Breast Density | June 28, 2016

New York is first state to require full insurance coverage without co-pays for all breast screenings, and supplemental imaging including MRI and breast ultrasound for women with dense breasts

fibroglandular densities, dense breasts, New York Legislation, New York Law,

New York State is taking the most aggressive action in the nation to improve access to breast cancer screening with a new law requiring health insurance to cover all screening and diagnostic imaging exams for the detection of breast cancer. The law includes supplemental imaging for all women. The law, signed by Gov. Andrew Cuomo June 27, removes insurance barriers for all women, including cost-sharing in the form of annual deductibles or coinsurance. It is the first law in the country requiring insurance companies to cover all of the costs of supplemental imaging to encourage women with dense breasts to seek additional screenings.

"Eliminating these insurance barriers will prevent women from paying out-of-pocket for breast cancer screening, including imaging for the detection of breast cancer, diagnostic mammograms, breast ultrasounds, or magnetic resonance imaging (MRI),” stated a press release issued by the governor’s office.

The new law (insurance bill S8093) goes into effect Jan. 1, 2017.

In 2013, New York was the first state to adopt a dense breast notification law to inform patients in clear, unambiguous language if their mammogram showed high fibroglandular densities, said New York advocate and Executive Director of DenseBreast-info.org, JoAnn Pushkin. She said after New York's law went into effect, two things became evident. The first was that further education was needed for both patients and their referring physicians about the implications of dense tissue. The second was that uncertainty over insurance coverage and high co-pay/deductibles could be deterrents to follow-up screening using breast ultrasound or MRI, which can see through dense breast issue.

One caveat on the new insurance bill, which it is not specific to New York, is that employer plans set up as "self-funded" are generally Exempt from state insurance laws. This means coverage might still be extended, but patient would have to pay co-pay and deductible.

For more information: DenseBreast-info.org

 

Related Breast Density Content:

List of State Insurance and Inform Laws Regarding Dense Breasts and Required Coverage for Supplemental Imaging

New Technology and Clinical Data in Breast Imaging

 

Additional Resources on ITN for Breast Imaging and Dense Breast technology Information

Mammographic Breast Density — What It Means

New Technology and Clinical Data in Breast Imaging (articles from 2017)

VIDEO: Advances and Trends in Breast Imaging

Trends in Breast Imaging

Making Sense of Dense Breasts

Dense Breast Tissue: Supplemental Imaging

Breast Density: Are You Informed?

 


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
Subscribe Now